TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
CRVO

CervoMed Inc.

Healthcare · Biotechnology

2.50$ -0.8% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CRVO
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
56.5% 89.7% 9.2% 37.0% 49.0% 60.3% 67.7% 100.0% 100.0% 99.9% 100.0% 96.4%
51.2% 87.7% 8.9% 34.0% 43.9% 58.4% 66.8% 98.6% 98.5% 78.1% 20.9% 35.2%
51.2% 87.7% 8.9% 34.0% 43.9% 58.4% 66.8% 98.6% 98.5% 78.1% 90.3% 89.2%
– – – – – – – 0.2% – 9.2% 5.2% 1.8%
28.2% – 39.6% 26.5% – – – – – – – –
15.1% 283.3% 49.4% 33.0% 47.5% 35.6% 31.2% – – – – –
10.8% 101.8% 47.5% 18.8% 14.2% 17.1% 10.5% 7.7% 316.4% 26.0% 9.0% 22.1%
5.5% 64.6% 25.4% 10.3% 4.4% 7.1% 8.8% 7.7% 316.4% 26.0% 9.0% 19.9%
– 18.7% 10.8% 2.1% – 0.5% 0.4% 10.9% 298.6% – – –
1.0% 18.7% 9.6% 2.0% 1.1% 5.2% 2.0% 2.5% 2.3% 6.6% 3.5% 6.2%
89.2% -1.8% 52.5% 81.2% 85.8% 82.9% 89.5% 92.3% -216.4% 74.0% 91.0% 77.9%
-176.0% -1,851.6% -344.2% -235.4% -439.1% -377.8% -381.9% -343.6% -1,257.2% -545.9% -164.2% -417.5%
0.0% 0.0% 0.1% 0.0% 0.2% 0.4% 2.6% 3.4% 12.5% 26.7% 18.7% 38.6%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?